Cases & Deals

Blue Point Capital sells controlling interest in TREK Diagnostic Systems

Clients Blue Point Capital Partners

Jones Day advised Blue Point Capital Partners in connection with the sale of a controlling interest in TREK Diagnostic Systems, a global provider of products for microbiology labs, to Magellan Biosciences, Inc.